Opens in a new tab

Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

FDA grants Breakthrough Device Designation to pulmonary hypertension early detection AI

{post_date: F d, Y}

FDA grants Breakthrough Device Designation to pulmonary hypertension early detection AI

Share
Related Articles